BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28681349)

  • 1. Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts.
    Franceschi E; Minichillo S; Brandes AA
    CNS Drugs; 2017 Aug; 31(8):675-684. PubMed ID: 28681349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.
    Farrell C; Shi W; Bodman A; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):269-359. PubMed ID: 33215345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-epidermal growth factor receptor therapy for glioblastoma in adults.
    Lee A; Arasaratnam M; Chan DLH; Khasraw M; Howell VM; Wheeler H
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013238. PubMed ID: 32395825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in therapy for glioblastoma.
    Clarke J; Butowski N; Chang S
    Arch Neurol; 2010 Mar; 67(3):279-83. PubMed ID: 20212224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of glioblastoma: State of the art and future directions.
    Tan AC; Ashley DM; López GY; Malinzak M; Friedman HS; Khasraw M
    CA Cancer J Clin; 2020 Jul; 70(4):299-312. PubMed ID: 32478924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.
    Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of vaccine therapies for patients with glioblastoma multiforme.
    Aguilar LK; Arvizu M; Aguilar-Cordova E; Chiocca EA
    Curr Treat Options Oncol; 2012 Dec; 13(4):437-50. PubMed ID: 22903697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the management of glioblastoma.
    Ma R; Taphoorn MJB; Plaha P
    J Neurol Neurosurg Psychiatry; 2021 Oct; 92(10):1103-1111. PubMed ID: 34162730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic options in recurrent glioblastoma--An update.
    Seystahl K; Wick W; Weller M
    Crit Rev Oncol Hematol; 2016 Mar; 99():389-408. PubMed ID: 26830009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard therapy for glioblastoma--a review of where we are.
    Nishikawa R
    Neurol Med Chir (Tokyo); 2010; 50(9):713-9. PubMed ID: 20885105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.
    Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y
    Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and signaling pathway alterations in glioblastoma: relevance to novel targeted therapies.
    Rao RD; Uhm JH; Krishnan S; James CD
    Front Biosci; 2003 May; 8():e270-80. PubMed ID: 12700121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma.
    Maxwell R; Jackson CM; Lim M
    Curr Treat Options Oncol; 2017 Aug; 18(8):51. PubMed ID: 28785997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trial.
    Mason WP; Cairncross JG
    Nat Clin Pract Neurol; 2005 Dec; 1(2):88-95. PubMed ID: 16932504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Targeted therapy in glioblastoma: update and perspectives].
    Idbaih A; Duran-Peña A; Alentorn A
    Bull Acad Natl Med; 2015 Nov; 199(8-9):1323-1329. PubMed ID: 29874421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives.
    Seystahl K; Gramatzki D; Roth P; Weller M
    Expert Opin Pharmacother; 2016 Jun; 17(9):1259-70. PubMed ID: 27052640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma.
    Haque A; Banik NL; Ray SK
    Neurochem Res; 2007 Dec; 32(12):2203-9. PubMed ID: 17676389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology 2011 CNS tumors update.
    Ahluwalia MS
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1495-7. PubMed ID: 21999122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Glioblastoma in Older Adults.
    Braun K; Ahluwalia MS
    Curr Oncol Rep; 2017 Oct; 19(12):81. PubMed ID: 29075865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of glioblastoma multiforme.
    Grossman SA; Batara JF
    Semin Oncol; 2004 Oct; 31(5):635-44. PubMed ID: 15497116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.